Home / Import refusals / 8JB-0093850-4/11/31

8JB-0093850-4/11/31

Fresenius Kabi USA, LLC — FEI 3002733956

Recent inspections

  • 1231341 (NAI Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113433 (NAI Mon Nov 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019250 (NAI Fri Apr 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897983 (NAI Mon Oct 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783661 (VAI Fri May 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 9SN-0007009-6/91/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/141/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/10 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/65 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9429853-3/71/1 (Thu Jul 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
March 22, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
62CDK30 HYDRALAZINE HCL (ANTI-HYPERTENSIVE)
Charges
179